Correction: Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Amendment: Post-Transplant Autoimmune and Inflammatory Disorders Following Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis by the EBMT Working Groups on Transplant Complications and Autoimmune Conditions

  • By

  • Arsene Mekinian

  • Artem Oganesyan

  • Zinaida Perić

  • Myriam Labopin

  • Urpu Salmenniemi

  • José Antonio Pérez Simón

  • Anke Verlinden

  • Ioanna Sakellari

  • Mohsen Alzahrani

  • Massimo Martino

  • Frédéric Baron

  • John A. Snowden

  • Hakan Ozdogu

  • Alexander Kulagin

  • Edgar Jost

  • Anna Torrent

  • Fabio Benedetti

  • Anna De Becker

  • Sylvie François

  • Montserrat Rovira

  • Hans Christian Reinhardt

  • Alessandra Biffi

  • Mark Ringhoffer

  • Pascal Ambron

  • Jose Luis López Lorenzo

  • Nabil Yafour

  • Alexandre Galvagni

  • Manuela Badoglio

  • Ivan Moiseev

  • Tobias Alexander

  • Mohamad Mohty

  • Olivier Fain

  • Raffaella Greco

  • Olaf Penack

  • September 25, 2026

Share

  • 1

    The article's title requires correction to accurately reflect the EBMT Complications Working Party's involvement.

  • 2

    The current title incorrectly attributes the study to both transplant complications and autoimmune diseases working parties.

  • 3

    The retrospective analysis focuses on secondary autoimmune and inflammatory diseases post-allogeneic hematopoietic stem cell transplantation.

  • 4

    The correction was published online on 27 July 2026 in Bone Marrow Transplantation.

  • 5

    The DOI for the correction is https://doi.org/10.1038/s41409-026-02981-3.

Original Source(s)

Correction: Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties

  • by Arsene Mekinian, Artem Oganesyan, Zinaida Perić, Myriam Labopin, Urpu Salmenniemi, José Antonio Pérez Simón, Anke Verlinden, Ioanna Sakellari, Mohsen Alzahrani, Massimo Martino, Frédéric Baron, John A. Snowden, Hakan Ozdogu, Alexander Kulagin, Edgar Jost, Anna Torrent, Fabio Benedetti, Anna De Becker, Sylvie François, Montserrat Rovira, Hans Christian Reinhardt, Alessandra Biffi, Mark Ringhoffer, Pascal Ambron, Jose Luis López Lorenzo, Nabil Yafour, Alexandre Galvagni, Manuela Badoglio, Ivan Moiseev, Tobias Alexander, Mohamad Mohty, Olivier Fain, Raffaella Greco, Olaf Penack

  • September 25, 2026

Related Content

Overall Survival Benefit and Long-Term Safety of Romiplostim in Persistent Chemotherapy-Induced Thrombocytopenia

Rapid WGS Improves Pediatric Diagnosis

Three-day whole-genome sequencing led to more personalized care for children newly diagnosed with cancer

  • October 15, 2026

  • 3 min
Overall survival of Black patients with newly diagnosed multiple myeloma in the era of triplet and quadruplet therapies